Alex Real Joins the Lab

The lab is excited to welcome back Alex Real, who has recently rejoined the lab as a postdoctoral fellow! Alex previously had been a lab member as an undergraduate student at Stanford, before completing his MD/PhD at Mt. Sinai in New York City.

Prior to his return to Stanford, Alex completed his PhD research under the mentorship of Dr. Arvin Dar.  His work involved unpacking the structural mechanism of action for the FDA approved MEK inhibitor Trametinib, and identifying more efficacious Trametinib analogs in models of difficult-to-treat cancers such as KRAS-mutant pancreatic ductal adenocarcinoma. Clinically, Alex has particular interest in solid-tumor malignancies as well as the intersection of LGBTQIA health, women’s health, and oncology. Outside of the lab, Alex has enjoyed a long career in dance - previously with the Los Angeles Ballet - but these days mostly dances for fun. 

Now, Alex is excited to explore protein engineering techniques for applications in oncology.